Bioactive natural products from orchids native to the Americas - A review.

Armando Mateus Pomini, Sandra Aparecida Sahyun, Silvana Maria DE Oliveira, Ricardo Tadeu DE Faria

Journal: Anais da Academia Brasileira de Ciencias 2023;95(suppl 1):e20211488

PMID: 37646708

Abstract

The purpose of this review is to provide information on the traditional uses, phytochemical and pharmacological studies performed with species of orchids native to the Americas and the Caribbean Islands. The treatment of inflammation is the most traditional use for plants of this family, specially in Central America, while anti-inflammatory and anticancer assays are oftenly reported in pharmacological investigations. From the chemical point of view, they are sources of phenanthrenoids and stilbenes, rare secondary metabolites not commonly found in other families of plants, as well as cycloartane triterpenes, pyrrolizidine alkaloids and flavonoids. Since just few species were chemically and pharmacologically studied, in comparison to the large number of native species (less than 0.5% of the total), the orchids of the New World may be an interesting niche for the discovery of new, bioactive natural products.

Address: State University of Maringá, Department of Chemistry, Colombo Avenue 5790, 87020-900 Maringá, PR, Brazil.; State University of Londrina, Department of Agronomy, Celso Garcia Road, Km 380, 86057-970 Londrina, PR, Brazil.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.